The CREST syndrome: a distinct serologic entity with anticentromere antibodies

The American Journal of Medicine
M J Fritzler, T D Kinsella

Abstract

The CREST syndrome is a variant of systemic sclerosis characterized by the presence of calcinosis. Raynaud's phenomenon, esophageal motility abnormalities, sclerodactyly and telangiectasia. The serums of 27 patients with the CREST syndrome have been examined for the presence of antinuclear antibodies. Twenty-six of 27 (98 percent) serums contained high titers (> one:80) of an antibody that produces a discrete speckled pattern of immunofluorescence on a human laryngeal carcinoma cell line (HEp-2). The antibody has been shown to react with the centromeric region of metaphase chromosomes. This antibody was also found in three of 14 patients with Raynaud's disease, in one of 60 patients with systemic lupus erythematosus, in three of 26 patients with systemic sclerosis with diffuse scleroderma and in one of 15 patients with mixed connective tissue disease. The antibody was not detected in the serums of patients with rheumatoid arthritis. Sjögren's sicca complex or linear scleroderma. Patients with osteoarthritis who were age- and sex-matched to the group with the CREST syndrome did not have anticentromere antibodies. Autoantibodies found in other connective tissue diseases (anti-DNA, anti-RNP, Sjögren's syndrome antigen B (anti-SS-B...Continue Reading

References

Jun 1, 1979·The Journal of Experimental Medicine·M B KahalehE C LeRoy
Jan 1, 1977·The Journal of Clinical Investigation·J F WolfeG C Sharp
Sep 1, 1978·The Journal of Clinical Investigation·M J Fritzler, E M Tan
Jan 1, 1977·Contributions to Nephrology·A L Sellers, V J Rosen
Nov 1, 1977·Annals of Internal Medicine·J F CipolettiG P Rodnan
Oct 1, 1975·Annals of Internal Medicine·D D NotmanE M Tan
Oct 1, 1968·Arthritis and Rheumatism·N F Rothfield, G P Rodnan
Jul 1, 1971·Annals of the Rheumatic Diseases·E Trell, C Lindström
Jul 1, 1968·Annals of the Rheumatic Diseases·P BeightonN G Cornes
Mar 1, 1971·The American Journal of Medicine·T B ReynoldsR L Peters
May 1, 1971·Annals of Internal Medicine·T A Medsger, A T Masi

❮ Previous
Next ❯

Citations

Jul 19, 2002·Arthritis and Rheumatism·Lionel SchachnaLivia Casciola-Rosen
Sep 5, 2002·Arthritis and Rheumatism·Daniel H SolomonUNKNOWN American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines
Aug 1, 1996·Arthritis and Rheumatism·J B RattnerM J Fritzler
Jan 1, 1993·Cell Motility and the Cytoskeleton·J B RattnerT J Yen
Jan 1, 1995·Rheumatology International·P CaramaschiL M Bambara
Jan 1, 1987·Rheumatology International·D J McNeilM J Fritzler
Jan 1, 1996·Molecular Biology Reports·M J Fritzler
Jun 1, 1989·Clinical Rheumatology·D J de RooijW J Van Venrooij
Jun 1, 1987·Clinical Rheumatology·W J Van VenrooijL B van de Putte
Mar 1, 1990·Clinical Rheumatology·C G Kallenberg
Sep 1, 1994·Clinical Rheumatology·M ZuberI Filler
Jan 1, 1990·Dysphagia·S R Fulp, D O Castell
Feb 9, 2005·Rheumatology International·Tsai-Ching HsuGregory J Tsay
Jun 29, 2006·Zeitschrift für Rheumatologie·E Genth, T Krieg
Oct 13, 2005·Clinical Rheumatology·Krisaree PakunpanyaSuchela Janwityanujit
Mar 12, 2009·Modern Rheumatology·Minoru SatohEdward K L Chan
Sep 1, 1987·The American Journal of Medicine·P PriolletE Housset
Jul 1, 1991·Mutation Research·M KratochvilH W Rüdiger
Apr 1, 1988·Psychiatry Research·F VillemainJ F Bach
Feb 15, 1985·Cancer Genetics and Cytogenetics·V J Goyanes
Feb 1, 2003·Clinica Chimica Acta; International Journal of Clinical Chemistry·José Manuel González-BuitragoWolfgang Papisch
Apr 9, 1988·Lancet·L J McNeilage, S Whittingham

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.